These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30123055)

  • 1. Correlation between
    Hu GN; Tzeng HE; Chen PC; Wang CQ; Zhao YM; Wang Y; Su CM; Tang CH
    Int J Med Sci; 2018; 15(11):1179-1186. PubMed ID: 30123055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine C-C Motif Ligand 4 Gene Polymorphisms Associated with Susceptibility to Rheumatoid Arthritis.
    Kuo SJ; Huang CC; Tsai CH; Hsu HC; Su CM; Tang CH
    Biomed Res Int; 2018; 2018():9181647. PubMed ID: 29955612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CCL4 gene polymorphisms and environmental factors on oral cancer development and clinical characteristics.
    Lien MY; Lin CW; Tsai HC; Chen YT; Tsai MH; Hua CH; Yang SF; Tang CH
    Oncotarget; 2017 May; 8(19):31424-31434. PubMed ID: 28404909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of CCL4 gene polymorphisms upon the progression of lung cancer in a Han Chinese cohort.
    Hu W; Chien SY; Ying P; Liu PI; Su CM; Tang CH
    Medicine (Baltimore); 2020 Jan; 99(3):e18906. PubMed ID: 32011520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development.
    Wang B; Chou YE; Lien MY; Su CM; Yang SF; Tang CH
    Int J Med Sci; 2017; 14(9):880-884. PubMed ID: 28824325
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Huang BF; Tzeng HE; Chen PC; Wang CQ; Su CM; Wang Y; Hu GN; Zhao YM; Wang Q; Tang CH
    Int J Med Sci; 2018; 15(6):580-586. PubMed ID: 29725248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of CCL4 rs1634507 and rs10491121 Polymorphisms with Susceptibility of Oral Squamous Cell Carcinoma in an Iranian Population: A Case-Control Study.
    Kadeh H; Eyni M; Parsasefat M; Miri-Moghaddam E
    Iran J Pathol; 2022; 17(2):210-216. PubMed ID: 35463731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of CD44 polymorphisms with genetic susceptibilities and clinico-pathologic characteristics in breast cancer].
    Zhou X; Wu CY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):807-11. PubMed ID: 23387202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis].
    Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
    Chen XH; Li XQ; Chen Y; Feng YM
    Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
    Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
    Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.
    Wang CQ; Tang CH; Wang Y; Jin L; Wang Q; Li X; Hu GN; Huang BF; Zhao YM; Su CM
    Sci Rep; 2017 Nov; 7(1):15887. PubMed ID: 29162880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
    Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
    Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
    Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.
    Wang Y; Yang SH; Hsu PW; Chien SY; Wang CQ; Su CM; Dong XF; Zhao YM; Tang CH
    Medicine (Baltimore); 2019 Nov; 98(44):e17854. PubMed ID: 31689877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
    Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
    Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CCL4 rs10491121 and rs1634507 gene polymorphisms with cancer susceptibility: trial sequential analysis and meta-analysis.
    Yang C; Song T; Mo Y; Wu P; Tian H; Wen L; Gao Y
    Front Oncol; 2023; 13():1133055. PubMed ID: 37593100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.